Three Reasons to Buy Gold Equities Today
Source: Frank Holmes, Frank Talk  (5/13/13)
"I believe the drivers for the yellow metal remain intact, so for investors who can tolerate the ups and downs, gold stocks are a compelling buy." More >

Precious Metal Royalties: The New Landscape
Source: JF Gunter of The Gold Report  (5/10/13)
In today's challenging finance environment, some miners are looking to royalty companies to fill the funding void. Royalty sales give the junior mining company capital to explore or build a mine in exchange for a percentage of future production. It is a win-win. Investors have exposure to gold profits, but are immune to much of the risk. Juniors get the money they need to move forward. But not all royalties are the same and a number of new types have entered the market to fill specific investing and funding niches. In this special primer from The Gold Report, we survey the heads of the companies to explain the role they see themselves playing in investment portfolios and the future of mining. More >

Placing Bets on Colombia: Paul Harris
Source: Brian Sylvester of The Gold Report  (5/10/13)
Some exploration projects in Colombia are advancing to the mine definition stage, says Paul Harris, the Colombia-based editor and publisher of the Colombia Gold Letter, and with the government starting to provide the level of administration that the sector needs, the country is poised for great things. In this interview with The Gold Report,
Harris discusses the implications of Colombia's 2001 mining code and which companies are leading the project development curve.
More >

Position Yourself for Big Returns in the Stem Cell Space: Jason Kolbert
Source: George S. Mack of The Life Sciences Report  (5/10/13)
Stem cell companies have languished long enough in micro-cap territory. The industry is now approaching highly visible phase 2 and phase 3 catalysts that will produce results never before seen in medicine. Managing Director and Senior Biotechnology Analyst Jason Kolbert of the Maxim Group has staked out a select group of nascent cell therapy companies positioned to reap huge gains for investors willing to diversify. In this interview with The Life Sciences Report, Kolbert reflects on the regenerative medicine space following the recent RegenMed Investor Day conference, and makes an enthusiastic case for his very best ideas. More >

Takeaway for Biotech Investors: Keep Targeted Cancer Immunotherapies in Mind
Source: Ray Blanco, The Daily Reckoning  (5/10/13)
"Increasingly, the great new medical technologies aren't coming from the pharmaceutical behemoths, but from scrappy little biotech upstarts. In few instances is this truer than in the field of cancer immunotherapy." More >

Best Investments 2013: How the Mining Mess Will Send Platinum Soaring
Source: Tony Daltorio, Money Morning  (5/10/13)
"While platinum's long-term outlook is bright, a short-term price catalyst is about to take place, as early as this week." More >

Six Superstars for Your Biotech Portfolio: John McCamant
Source: Tracy Salcedo-Chourré of The Life Sciences Report  (5/9/13)
We are in the "golden age," of biotech, and Medical Technology Stock Letter Editor John McCamant has innovative ideas on how to glean profits from the renaissance. Investors should be looking at companies with excellent management and platform technologies that offer multiple opportunities for success. McCamant names his favorites in this interview with The Life Sciences Report, including one company with a radical therapy that harkens back to the days before the reign of hand sanitizer. More >

Keith Schaefer Names the Last-Standing Shale Plays
Source: Peter Byrne of The Energy Report  (5/9/13)
Shale oil has been North America's great experiment, says Oil & Gas Investments Bulletin Editor Keith Schaefer. But in this interview with The Energy Report, he questions the experiment's success and predicts steep declines ahead, with just a few formations left to supply the market. The question is what shale play will last the longest? Read on to find out how—and when—to get positioned for the end of the shale revolution. More >

The Real Reason Gold Fell—and Why It Has Already Stabilized: Lawrence Roulston
Source: Brian Sylvester of The Gold Report  (5/8/13)
Things are upside down in the gold market. Valuations are irrationally low, while global consumerism fuels demand and supply comes up short. Lawrence Roulston, editor and publisher of Resource Opportunities, advises people to trust their guts as well as the numbers when weeding through prospective investments. In this interview with The Gold Report,
he skirts around conspiracy theories regarding the recent gold sell-off and keeps his advice simple: lower expectations, get rid of poorly performing investments and load up on the companies going cheap. If you push against the trend, you might come out with your feet on the ground.
More >

Mr. Spock Would Definitely Find Current Gold Price Levels Illogical
Source: Lawrence Williams, Mineweb  (5/8/13)
"Unprecedented demand for physical gold does not even seem to be having any impact at all on the metal price as high frequency traders rule the day. Illogical!" More >

Richard Karn: New Mining Technology Could Increase Profits
Source: JT Long of The Metals Report  (5/7/13)
The need for low-cost production may prove to be the mother of invention, argues Emerging Trends Report Editor Richard Karn. Although miners are far more technologically conservative than oil producers, today's tough financing environment may prompt technological advancements in a sector that has historically approached processing "with brute force rather than finesse," says Karn. In this interview with The Metals Report, Karn explores the possibilities for technological advancement in the mining space and tells us how we could (theoretically) reach a state of "resource equilibrium." More >

Bill Powers: Pickens and Stansberry Wrong, Shale Gas Production to Fall
Source: Tom Armistead of The Energy Report  (5/7/13)
Energy pundits sing natural gas' praises, but Bill Powers, author of "Cold, Hungry and in the Dark: Exploding the Natural Gas Supply Myth," isn't buying it. He sees serious flaws in how reserves are reported, and his own research shows steep, across-the-board production declines in the near future. Nonetheless, he expects a multiyear bull run for the resource, and recommends investors get positioned before scarcity hits—just five to seven years from now. Find out which companies Powers is betting on in this interview with The Energy Report. More >

Case in Point: How Following this 5-Step Biotech Investing Strategy Can Double Your Money
Source: Michael Robinson, Strategic Tech Investor  (5/7/13)
"This strategy can avoid some of the biotech sector's biggest risks, while giving you access to the high growth and high returns. And it still gives us the chance to find double-your-money stocks—the chief objective of the Five Tech-Wealth-Investing Rules." More >

Porter Stansberry vs. Marin Katusa: I Win, You Lose!
Source: Marin Katusa, Casey Research  (5/7/13)
"This means there are tremendous opportunities to profit while we wait for the rest of the world to catch up." More >

Special Report from the SME Conference: How to Find Money in Any Market
Source: JT Long of The Gold Report  (5/6/13)
Money: Mining companies need it and investors want to know that companies will use that money to make them money. An innovative conference sponsored by the Society for Mining, Metallurgy and Exploration (SME), called "Current Trends in Mining Finance—An Executive's Guide: What Are Lenders, Investors Looking For?", brought together about 145 experts who were actively funding and running companies—and looking for answers. In this interview with The Gold Report,
SME Executive Director David Kanagy and Conference Co-Chair Tim Alch share some insights about alternative funding that could help more companies survive the year.
More >

Are Palladium Stockpiles Running Out?
Source: Sholom Sanik, Resource Investor  (5/6/13)
"The market is absorbing a supply-side shock from two fronts." More >

How to Make Money in Range-Bound Energy Markets
Source: Kent Moors, Oil & Energy Investor  (5/6/13)
"Hedge using market sectors." More >

Ryan Walker: Tweet Retreat Hasn't Changed Gold's Story
Source: Brian Sylvester of The Gold Report  (5/3/13)
Investors were shaken by the market's death-defying drop and recovery in a matter of minutes recently. But the "tweet retreat" hasn't changed the reasons why investors need gold companies in their portfolio. Ryan Walker, a mining analyst with Casimir Capital in Toronto, tells investors to look past the headlines to what underpins the market. In this interview with The Gold Report, Walker says all the cash pumped into the economy has to start driving inflation at some point. More >

James Dines Follows His Prediction of a Commodity Crash with Another One the Mainstream Media Is Ignoring
Source: JT Long of The Gold Report  (5/3/13)
When the metals markets tumbled in mid-April, The Gold Report reached out to "the original investor bug" and author of The Dines Letter, James Dines, for perspective. He predicted a crash in commodity prices two years ago based on his analysis of a weak Chinese economy. Next, he says, will be a bond market bust once interest rates start to climb. This will lead to "a stampede to get out of bonds like a herd of elephants attempting to exit through a revolving door." How can investors protect themselves? That is Dinesism #38. More >

Physical Gold-Silver Shortage Could Benefit Undervalued Miners
Source: Jeb Handwerger, Gold Stock Trades  (5/3/13)
"We may see a very powerful rebound as short covering and record investment demand returns to the precious metal sector." More >

Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Source: George S. Mack of The Life Sciences Report  (5/2/13)
In January 2013, The Life Sciences Report debuted its biotech Watchlist, which outlined ideas for investors keyed to catalysts in the drug development process that typically move biotechnology stocks. All stocks are affected by catalysts, but nowhere do they provide more leverage (or deleverage) than in biotech. We predicted the new year would present legitimate prospects for portfolio growth. So far, that has been the case. Although the party has given way to some fatigue, the punch bowl is still on the table and the biotech upswing continues. More >

James McIlree: Three Companies Could Transform Power Production
Source: Peter Byrne of The Energy Report  (5/2/13)
Energy tech companies have a business model that's closer to Apple Inc. than Apache Corp. In other words, it's all about the new product. The products Dominick & Dominick Analyst James McIlree is excited about offer major benefits like improved geological mapping for oil and gas explorers, or electric grid safety for energy utilities. In an interview with The Energy Report, McIlree talks about his favorite companies in the energy tech space and how understanding product cycles can help investors time their buys. More >

Silver Prices in 2013: The Reasons for a Bold Forecast
Source: Diane Alter, Money Morning   (5/2/13)
"Investing now in beaten down silver could prove very rewarding." More >

How to Stress Test Gold Equities: Joe Mazumdar
Source: Peter Byrne of The Gold Report  (5/1/13)
Gold prices are down in the short term, but the commodity metal is here to stay, says geologist Joe Mazumdar. In this interview with The Gold Report,
the Canaccord Genuity analyst assesses the current situation and compares the performance potential of the majors with the mid caps. He backs up his analysis and predictions with a few solid companies that are positioned to weather the storm.
More >

Gold Stocks to Rebound in May
Source: Jordan Roy-Byrne, The Daily Gold  (5/1/13)
"Sell in May and don't go away. Sell and buy gold stocks." More >